4.4 Colorectal Tumours, FIT and Diagnostic Referral
Key Takeaways
Persistent bleeding, altered bowel habit, anaemia or a mass need clinical assessment and safety-netting.
BowelScreen is a screening programme for eligible people without symptoms. Symptomatic FIT supports triage and should be interpreted alongside the clinical picture.
Colonoscopy and histology help establish the diagnosis. Stage colon and rectal tumours with appropriate imaging and use the NCCP mismatch-repair testing pathway.
Start with symptoms and examination
Persistent rectal bleeding, a sustained change in bowel habit, otherwise unexplained iron-deficiency anaemia, weight loss and an abdominal or rectal mass can indicate colorectal cancer. Assess the characteristics and duration, stool changes, medication, relevant family history and previous screening or endoscopy. Blood loss from a proximal lesion may first present as iron deficiency. Distal lesions can produce altered bowel habit, tenesmus or visible blood. Symptoms overlap with benign disease. A haemorrhoid or a negative digital rectal examination does not rule out another lesion. Evaluate the abdomen and do anorectal examination where indicated and with consent. Obtain blood count and interpret ferritin and other iron tests in context.
Assess for urgency before planning outpatient tests. Severe pain with distension, vomiting, absolute constipation or peritonism can indicate obstruction or perforation. Major bleeding or circulatory instability needs acute resuscitation and hospital assessment. In a stable patient with a palpable rectal or abdominal mass or significant clinical suspicion, use the appropriate NCCP or local colorectal assessment route. The NCCP pathway directs a palpable rectal or abdominal mass to urgent colorectal clinical review. It lists separate direct-to-endoscopy criteria for appropriate patients, based on symptoms, age and other risk factors. Include examination, duration, blood results and relevant family history. Arrange the full blood count requested for referral and avoid delaying the referral for imaging. Keep track of arranged tests and referrals and give a specific review plan.
FIT has two different settings in Ireland
| Setting | Purpose | What to do with the result |
|---|---|---|
| BowelScreen population programme | Screen eligible people without symptoms. From April 2026 the service covers ages 57–71, with invitations every two years. | A positive screen leads to programme assessment and offer of colonoscopy. New symptoms need clinical assessment even after a recent negative screen. |
| Symptomatic primary care FIT | Quantify faecal haemoglobin as an adjunct to clinical assessment and blood tests. With a symptomatic patient, use the relevant local primary care and endoscopy pathway. | A result helps triage, but persistent or worrying symptoms, iron deficiency or an examination finding can require further investigation despite a low FIT. If FIT is unavailable or the patient does not return it, arrange follow-up and pursue indicated referral. |
The HSE National Endoscopy Programme position paper supports symptomatic FIT in lower-risk presentations and selective use in higher-risk presentations according to local arrangements. A symptomatic threshold discussed in that paper is 10 micrograms of haemoglobin per gram of faeces. The screening programme uses a different threshold. Use the laboratory units and current local protocol rather than applying a population screening cut-off to symptoms. Refer when the clinical picture warrants it. A patient with concerning findings should neither wait for a screening invitation nor be excluded from investigation by FIT alone.
Worked decision. A 67-year-old with persistent change in bowel habit, a palpable rectal mass and anaemia has previously had a reassuring screening result. Record the findings and arrange urgent colorectal clinic assessment. The symptoms, examination and blood count remain relevant, irrespective of the screening result or access to a new FIT.
NCCP colorectal referral pathway · HSE symptomatic FIT position paper · Current BowelScreen programme.
Understand diagnosis, staging and initial management
Colonoscopy can identify and sample a lesion, assess the rest of the colon where feasible, and remove selected polyps. CT colonography can be considered in appropriate circumstances, for example if colonoscopy is incomplete or unsuitable. An abnormality detected by CT colonography may still need endoscopic tissue or treatment. CEA may be used in a specialist monitoring programme. It does not establish the diagnosis or decide GP referral. Histology distinguishes adenoma, invasive adenocarcinoma and other diagnoses.
After diagnosis, the team typically uses staging CT of thorax, abdomen and pelvis to look for spread. For rectal cancer, pelvic MRI assesses local anatomy and disease extent for treatment planning. The TNM system describes primary tumour extent, regional nodes and distant metastases. In the bowel, depth of local invasion matters to the T category. Tumour size alone does not establish the T category. A patient with confirmed cancer is discussed by a multidisciplinary team. Factors include site, local and distant stage, fitness, pathology, preferences and whether symptoms such as obstruction require urgent intervention.
- Localised colon cancer: Oncological resection is a principal treatment. Adjuvant systemic therapy is considered by stage and individual risk. Node-positive stage III disease commonly prompts a postoperative discussion of adjuvant chemotherapy.
- Rectal cancer: The tumour’s level and local MRI findings help determine the use and sequencing of surgery, radiotherapy and systemic treatment. Locally advanced disease may need neoadjuvant treatment.
- Metastatic disease: Consider symptom control and systemic therapy based on the tumour and patient. Some patients with limited metastases may be candidates for local treatment after specialist evaluation. Do not assign treatment from colonoscopy findings alone.
The Irish NCCP recommends tumour mismatch-repair testing in newly diagnosed colorectal cancer as part of the Lynch syndrome pathway. An abnormal result can arise through sporadic changes and is not by itself a germline diagnosis. Further tumour tests and a genetics referral or germline test may be needed. Explain how heritable findings can inform counselling and management for the patient and relatives. Use appropriate consent and specialist pathways.
Irish colon cancer guideline · NCCP rectal cancer guideline · Current Irish neoadjuvant rectal cancer guidance · NCCP Lynch pathway · NCCP current systemic regimens.
A 63-year-old has a persistent change in bowel habit, iron-deficiency anaemia and a palpable rectal mass. A recent BowelScreen result was negative. The patient is clinically stable and has no acute obstruction. What is the most appropriate action?
Repeat a population BowelScreen test and refer only if it is positive
Measure CEA and refer only if the value is raised
Wait until the next routine screening invitation
Arrange urgent colorectal clinic assessment and provide the symptoms, examination and blood results
Sections you finish are checked off in the contents.